about
Involvement of B cells in non-infectious uveitisMacrophages and Uveitis in Experimental Animal ModelsClinical and visual outcomes of patients with uveitis in the mid-Atlantic United StatesIntermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA.Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience.Etiology and treatment of the inflammatory causes of cystoid macular edema.Mammalian telomeric DNA suppresses endotoxin-induced uveitisThe multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.Bilateral macular thickening in mild unilateral anterior uveitis: is HLA-B27 involved?Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human lens epithelial cells: apoptosis through the formation of 3-hydroxykynurenine.Clinical course and visual outcome in patients with diabetes mellitus and uveitis.Incidence of visual improvement in uveitis cases with visual impairment caused by macular edemaGreen tea extract treatment alleviates ocular inflammation in a rat model of endotoxin-induced uveitis.Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study.Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patientsUse of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population.Macular sensitivity and fixation patterns in normal eyes and eyes with uveitis with and without macular edema.Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitisBenefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and FollQuantifying Retinal Microvascular Changes in Uveitis Using Spectral-Domain Optical Coherence Tomography Angiography.Age-Related Cataract Is Associated with Elevated Serum Immunoglobulin E Levels in the South Korean Population: A Cross-Sectional Study.Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro.Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis.Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in RatsThe pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-upOcular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE StudyAcute anterior uveitis in primary care.Retisert: is the new advance in treatment of uveitis a good one?The impact of macular edema on visual function in intermediate, posterior, and panuveitis.Vascular adhesion protein 1 in the eye.Cyclosporin-A associated malignancy.Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USAA national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis.Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis.Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis.Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis.Emerging approaches to the treatment of uveitis: patents of 2000 - 2004.Dexamethasone for ocular inflammation.
P2860
Q26766611-3BD89F49-A459-4334-B97C-26837175ECDBQ26828497-AF731B96-AB6A-4334-A5B0-82EAC5BD8D74Q30278649-50AAD1F6-1EA7-4EB0-AEC0-4BD412A64220Q30278739-6F96CD59-3157-4587-A53F-7E56F44060B7Q33757440-B5D643A6-BC27-4FFE-8735-09614E19426FQ34077613-E4B059F8-D5CB-46B7-A849-51057C5F1E87Q34121345-6FD680AD-5DA0-4FD4-8E57-55E922986184Q34286402-0EBBF37C-A302-48D4-A63C-24EA3AD7A42CQ34354352-03AF2D78-0D6A-4F44-B60F-C5B9210AE2F6Q34619243-983C5122-0F72-4265-95AD-616DFDC1F065Q34694705-5688D5E7-1524-468D-AB13-FE5E632BD84DQ35065882-60A99862-B0FD-4E96-A4E7-464659DA2959Q35219645-EA989F97-EE23-495E-839E-3B5E406962B2Q35319079-6E80A5F3-C016-48C6-BBFB-FB708E1DB394Q35638594-4B476049-41B3-4962-A6E2-4B5B4A158367Q35699360-8E6196A3-1F29-4801-AD48-2843BA9AA523Q35752563-DC4317C7-E7E5-468C-8BD0-80CCECFDAF2CQ35935970-6AB35EE4-4E19-466E-8096-FCBA1FF8E472Q36082770-2504AD3D-5A70-442E-ABD0-186DBEA5AFE4Q36090415-391D5335-EC48-4EB9-839B-41BEC7B18534Q36122877-EF6DBA42-73D1-4917-8C23-B2B565F0299EQ36197386-2CE2BFA2-9CBF-43A9-B05C-AEA993C55E48Q36334208-6C8DFD9B-4095-43F7-8871-370097F10EB4Q36407719-5FC3F55F-A335-4642-AA8E-25DEA32D26B1Q36424996-D0F7839B-00BE-46C6-8F12-3EC15221EC0EQ36441711-0D337185-560A-4569-9B35-2B50688D4130Q36686788-1BF546FF-877F-4677-922C-06F5CAB4D64DQ36722548-7D45D3B6-0ED4-455B-8108-8E9BA8FD2811Q36740602-E7CFB20B-AA70-4D8D-989F-BFA91A8D8DDBQ36753097-8B8FABB6-8D6A-4217-84A4-7500092CB047Q36814725-816CE959-280F-4FF8-B139-338C52A4428EQ36942812-7AED68F3-1DA1-46EA-A7B8-10B20723923BQ37247310-7AFCDFE1-B6E9-4915-BD2D-5A90E31C4456Q37315338-5D9DD81B-1D94-4064-9E5D-8B03686DC8C8Q37348275-86DAD7D1-D4EA-46B2-9B8A-06C8D2B1055DQ37349073-BC1EBD67-8FA1-4179-BAF6-642343E0827FQ37482393-87A0D3DD-AAA9-4748-A829-D30708498BD2Q37551899-D22C85EA-68F3-43D6-9C4E-D0B910CF26ACQ37689191-658E690D-8E71-4A09-A0BA-419FDEE0375BQ37860330-57AA288B-931F-44FC-934C-54BA0ACF2E48
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Degree, duration, and causes of visual loss in uveitis.
@ast
Degree, duration, and causes of visual loss in uveitis.
@en
type
label
Degree, duration, and causes of visual loss in uveitis.
@ast
Degree, duration, and causes of visual loss in uveitis.
@en
prefLabel
Degree, duration, and causes of visual loss in uveitis.
@ast
Degree, duration, and causes of visual loss in uveitis.
@en
P2093
P2860
P356
P1476
Degree, duration, and causes of visual loss in uveitis
@en
P2093
P2860
P304
P356
10.1136/BJO.2003.037226
P407
P577
2004-09-01T00:00:00Z